| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/05/2005 | EP1492867A2 Identification of virulence associated regions rd1 and rd5 enabling the development of imrpoved vaccines of m. bovis bcg and m. microti |
| 01/05/2005 | EP1492819A2 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine |
| 01/05/2005 | EP1492817A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 01/05/2005 | EP1492813A2 Ox40r binding agents |
| 01/05/2005 | EP1492812A2 Modulator of the notch signalling pathway and use thereof in medical treatment |
| 01/05/2005 | EP1492811A1 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 01/05/2005 | EP1492807A2 Novel proteins and nucleic acids encoding same |
| 01/05/2005 | EP1492806A2 Human smooth muscle myosin heavy chain |
| 01/05/2005 | EP1492805A2 System for tracing animal products |
| 01/05/2005 | EP1492804A1 Process for isolating nucleic acid with chaotrope agents and ammonium compounds |
| 01/05/2005 | EP1492568A1 Cancer treatment method comprising administration of an erb-family inhibitor and a raf and/or ras inhibitor |
| 01/05/2005 | EP1492565A2 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty |
| 01/05/2005 | EP1492563A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/05/2005 | EP1492559A2 Truncated 24 kda basic fibroblast growth factor |
| 01/05/2005 | EP1492555A2 Compositions and methods for modulation of effects on phagocyte and lymphoid cell population |
| 01/05/2005 | EP1492552A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| 01/05/2005 | EP1492525A2 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 01/05/2005 | EP1492516A2 Use of mob-5 in pain |
| 01/05/2005 | EP1492476A1 Device for mixing and/or injecting cements |
| 01/05/2005 | EP1492410A1 Triglyceride fat |
| 01/05/2005 | EP1492404A2 Novel spinosyn-producing polyketide synthases |
| 01/05/2005 | EP1456349A4 Expression system |
| 01/05/2005 | EP1420643A4 Enhancement of transfection of dna into the liver |
| 01/05/2005 | EP1412481A4 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 01/05/2005 | EP1393067A4 Encapsulated cell indicator system |
| 01/05/2005 | EP1390535A4 Combinatorial libraries of monomer domains |
| 01/05/2005 | EP1389902A4 Manipulation of sucrose synthase genes to improve stalk and grain quality |
| 01/05/2005 | EP1381268A4 Method for modifying plant biomass |
| 01/05/2005 | EP1364201A4 Ligand sensor devices and uses thereof |
| 01/05/2005 | EP1326523A4 Imaging of enzymatic activity |
| 01/05/2005 | EP1265484A4 Materials and methods for the regeneration of plants from cultured plant tissue |
| 01/05/2005 | EP1218546A4 Incorporation of modified nucleotides by archaeon dna polymerases and related methods |
| 01/05/2005 | EP1218492A4 Method and system for non-random selection of plant and tissue products |
| 01/05/2005 | EP1211933A4 Pa28 modified transgenic mice |
| 01/05/2005 | EP1200580B1 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 01/05/2005 | EP1190096A4 Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms |
| 01/05/2005 | EP1144669A4 Method and apparatus for the automated generation of nucleic acid ligands |
| 01/05/2005 | EP1102841A4 Method for selective and optionally reversible degeneration of somatic plant tissue |
| 01/05/2005 | EP1018549B1 Method for isolating dna |
| 01/05/2005 | EP1012332A4 Array-based detection of genetic alterations associated with disease |
| 01/05/2005 | EP0994956B1 Male tissue-preferred regulatory region and method of using same |
| 01/05/2005 | EP0983386B1 Method based on the use of bacteriophages for the detection biological molecules in biological samples |
| 01/05/2005 | EP0837930B1 A TRP-226 MUTANT HUMAN GLANDULAR KALLIKREIN-1 (hK2) |
| 01/05/2005 | EP0730609B1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 01/05/2005 | EP0719333B1 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | DE10326189A1 Bakterielle Träger für Nukleotidsequenzen kodierend für Wirkstoffe Bacterial support for nucleotide sequences coding for agents |
| 01/05/2005 | DE10325026A1 Bakterien mit erhöhter Proteinsekretion, Nukleotidsequenzen codierend für ein SecA Protein mit erhöhter Proteinsekretion sowie Verfahren zur Produktion von Proteinen Bacteria with increased protein secretion, nucleotide sequences coding for a protein with increased SecA protein secretion as well as methods for producing proteins |
| 01/05/2005 | CN1561396A Method for regulating the expression of genes carried on a viral vector |
| 01/05/2005 | CN1561395A Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 |
| 01/05/2005 | CN1561394A Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| 01/05/2005 | CN1561391A Recombinant bacterial phytases and uses thereof |
| 01/05/2005 | CN1561390A PEG-modified uricase |
| 01/05/2005 | CN1561344A Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 01/05/2005 | CN1561343A Soluble T cell receptor |
| 01/05/2005 | CN1561229A Virus coat protein/receptor chimeras and methods of use |
| 01/05/2005 | CN1561225A Modulation of leukocyte-endothelial interactions following ischemia |
| 01/05/2005 | CN1561223A New drug |
| 01/05/2005 | CN1561186A Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity |
| 01/05/2005 | CN1560609A Fluorescence polarization screening method |
| 01/05/2005 | CN1560267A Methods and apparatus for template capture and normalization for submicroliter reaction |
| 01/05/2005 | CN1560261A Production process of whole silkworm chrysalis powder containing lactoferrbumin and its peptide |
| 01/05/2005 | CN1560260A Rice transformation process lead-in by agrobacterium induced |
| 01/05/2005 | CN1560259A DNA vaccine carrier of carring SV40 enhancer element |
| 01/05/2005 | CN1560258A Preparation process of antibacterial peptide |
| 01/05/2005 | CN1560257A Expression carrier of laccase, microorganism strain of expression, laccase protein of expression and application thereof |
| 01/05/2005 | CN1560256A Expression carrier of low oxygen inducing microorganusm and constructure process and application thereof |
| 01/05/2005 | CN1560255A Coding sequence of Chinese yew tarad-ane C13-lateral chain-N-benzoyl transiting enzymic protein |
| 01/05/2005 | CN1560254A Gene of L-lactate dehydrogenase, recombined carrier containing said gene and host-cell thereof |
| 01/05/2005 | CN1560253A Preparation of antibiotic hPAB with multicopy tandem peptide |
| 01/05/2005 | CN1560252A Nucleotide to 0-antigen specificity of escherichia coli 0154 type |
| 01/05/2005 | CN1560251A Nucleotide to 0-antigen specificity of Escherichia coli 0140 type |
| 01/05/2005 | CN1560250A Coding sequence of Chinese yew agglutinant protein |
| 01/05/2005 | CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 01/05/2005 | CN1560248A Tiantan remocined vaccine virus of IFN-alpha receptor gene (B8R) deletion and application thereof |
| 01/05/2005 | CN1560247A Primary sequence for identifing cucumber ampho disease and its identification method |
| 01/05/2005 | CN1560244A Recombined D-hydantoin enzyme and application thereof |
| 01/05/2005 | CN1560242A Mutant alpha-amylase |
| 01/05/2005 | CN1560240A Cell strain transfacted by deletion multant gene using histo type cellulolytic proenzyme as activator |
| 01/05/2005 | CN1560239A Cell strain transfacted by delection/Point mutont gene using histo type cellulolytic proenzyme as activator |
| 01/05/2005 | CN1560229A Process of preparing D-amino acid oxydase |
| 01/05/2005 | CN1560082A Chimeric antibod of antihumon recombined basicity fibroblast growth factor and construction and using thereof |
| 01/05/2005 | CN1560080A Corpuscles of stannius protein, stanniocalcin |
| 01/05/2005 | CN1560076A Derivant with reducing calcium gene related peptide and preparation process thereof |
| 01/05/2005 | CN1560066A Recombined immune toxin protein of anticryptic sporozoan and its preparation process and medical application |
| 01/05/2005 | CN1559202A Method for preparing transgenic mouse with central nervous system specific expression Cre recombinase |
| 01/05/2005 | CN1559187A Method for selectively breeding cabbage type rape dominant karyon male sterility isozygotic wo-purpose line |
| 01/05/2005 | CN1183259C Genotyping kit for diagnosis of human papillomavirus infection |
| 01/05/2005 | CN1183257C Gene transfer method |
| 01/05/2005 | CN1183256C Enhanced carotenoid accumulation in storage organs of genetically engineered plants |
| 01/05/2005 | CN1183255C Expression system for producing proteins |
| 01/05/2005 | CN1183254C Polypeptides |
| 01/05/2005 | CN1183253C DNA polymerase-related factors |
| 01/05/2005 | CN1183252C Novel cytochrome p450 monooxygenases and their use for oxidizing organic compounds |
| 01/05/2005 | CN1183251C Method for recoverying recombinant HBsAg |
| 01/05/2005 | CN1183250C Virus with specigic reproduction in tumor well and effective expression of tumor angiogenesis nihibitory factor and its construction method |
| 01/05/2005 | CN1183249C Frozen food product |
| 01/05/2005 | CN1183246C Extracellent expression of cellulose binding domains (CBD) using bacillus |
| 01/05/2005 | CN1183160C Human anti-factor IX/IXa antibodies |
| 01/05/2005 | CN1183158C Exendin analogue, processes for their preparation and medicaments containing them |